{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:08:30Z","timestamp":1776283710632,"version":"3.50.1"},"reference-count":153,"publisher":"Bentham Science Publishers Ltd.","issue":"34","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Astrocytes are a multifunctional subset of glial cells that are important in maintaining\nthe health and function of the central nervous system (CNS). Reactive astrocytes\nmay release inflammatory mediators, chemokines, and cytokines, as well as neurotrophic\nfactors. There may be neuroprotective (e.g., cytokines, like IL-6 and TGF-b) and neurotoxic\neffects (e.g., IL-1\u03b2 and TNF-a) associated with these molecules. In response to\nCNS pathologies, astrocytes go to a state called astrogliosis which produces diverse and\nheterogenic functions specific to the pathology. Astrogliosis has been linked to the progression\nof many neurodegenerative disorders. Phytochemicals are a large group of compounds\nderived from natural herbs with health benefits. This review will summarize how\nseveral phytochemicals affect neurodegenerative diseases (e.g., Alzheimer\u2019s disease,\nHuntington\u2019s disease, amyotrophic lateral sclerosis, and Parkinson\u2019s disease) in basic\nmedical and clinical studies and how they might affect astrogliosis in the process.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867330666230504121523","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T04:49:08Z","timestamp":1683262148000},"page":"5550-5566","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Phytochemicals as Substances that Affect Astrogliosis and their Implications for the Management of Neurodegenerative Diseases"],"prefix":"10.2174","volume":"31","author":[{"given":"Fatemeh","family":"Forouzanfar","sequence":"first","affiliation":[{"name":"Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"},{"name":"Department of\nNeuroscience, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Mohammad","family":"Pourbagher-Shahri","sequence":"additional","affiliation":[{"name":"Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"},{"name":"Department of Neuroscience, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzaneh","family":"Vafaee","sequence":"additional","affiliation":[{"name":"Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"},{"name":"Department of\nNeuroscience, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thozhukat","family":"Sathyapalan","sequence":"additional","affiliation":[{"name":"Department\nof Academic Diabetes, Endocrinology and Metabolism, Hull York Medical School, University of Hull, Hull-\nHU3 2JZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[{"name":"Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University\nof Medical Sciences, Mashhad, Iran"},{"name":"Applied Biomedical Research Center, Mashhad University of Medical\nSciences, Mashhad, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/jnc.15565","volume":"164","author":"Kumar A","year":"2023","unstructured":"Kumar A; Fontana IC; Nordberg A; Reactive astrogliosis: A friend or foe in the pathogenesis of Alzheimer\u2019s disease. J Neurochem  2023,164(3),309-324","journal-title":"J Neurochem"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1471-4159.2012.07664.x","volume":"121","author":"Parpura V.","year":"2012","unstructured":"Parpura V.; Heneka M.T.; Montana V.; Oliet S.H.R.; Schousboe A.; Haydon P.G.; Stout R.F.; Spray D.C.; Reichenbach A.; Pannicke T.; Pekny M.; Pekna M.; Zorec R.; Verkhratsky A.; Glial cells in (patho)physiology. J Neurochem  2012,121(1),4-27","journal-title":"J Neurochem"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","volume":"119","author":"Sofroniew M.V.","year":"2010","unstructured":"Sofroniew M.V.; Vinters H.V.; Astrocytes: Biology and pathology. Acta Neuropathol  2010,119(1),7-35","journal-title":"Acta Neuropathol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0006-8993(71)90668-8","volume":"28","author":"Eng L.F.","year":"1971","unstructured":"Eng L.F.; Vanderhaeghen J.J.; Bignami A.; Gerstl B.; An acidic protein isolated from fibrous astrocytes. Brain Res  1971,28(2),351-354","journal-title":"Brain Res"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1080\/17482960701278612","volume":"8","author":"Guo Y.","year":"2007","unstructured":"Guo Y.; Liu Y.; Xu L.; Wu S.; Yang C.; Wu D.; Wu H.; Li C.; Astrocytic pathology in the immune-mediated motor neuron injury. Amyotroph Lateral Scler  2007,8(4),230-234","journal-title":"Amyotroph Lateral Scler"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.lfs.2006.09.039","volume":"80","author":"Zhang L.","year":"2007","unstructured":"Zhang L.; Zhang W.P.; Chen K.D.; Qian X.D.; Fang S.H.; Wei E.Q.; Caffeic acid attenuates neuronal damage, astrogliosis and glial scar formation in mouse brain with cryoinjury. Life Sci  2007,80(6),530-537","journal-title":"Life Sci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.ajpath.2011.05.047","volume":"179","author":"Serrano-Pozo A.","year":"2011","unstructured":"Serrano-Pozo A.; Mielke M.L.; G\u00f3mez-Isla T.; Betensky R.A.; Growdon J.H.; Frosch M.P.; Hyman B.T.; Reactive glia not only associates with plaques but also parallels tangles in Alzheimer\u2019s disease. Am J Pathol  2011,179(3),1373-1384","journal-title":"Am J Pathol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/bpa.12537","volume":"27","author":"Verkhratsky A.","year":"2017","unstructured":"Verkhratsky A.; Zorec R.; Parpura V.; Stratification of astrocytes in healthy and diseased brain. Brain Pathol  2017,27(5),629-644","journal-title":"Brain Pathol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2217\/fnl.12.90","volume":"8","author":"Verkhratsky A.","year":"2013","unstructured":"Verkhratsky A.; Rodr\u00edguez J.J.; Parpura V.; Astroglia in neurological diseases. Future Neurol  2013,8(2),149-158","journal-title":"Future Neurol"},{"key":"ref=10","first-page":"703810","volume":"15","author":"Moulson A.J.","year":"2021","unstructured":"Moulson A.J.; Squair J.W.; Franklin R.J.M.; Tetzlaff W.; Assinck P.; Diversity oflology: Heterogeneity or plasticity? Future Neurol  2021,15,703810","journal-title":"Future Neurol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrn2978","volume":"12","author":"Robel S.","year":"2011","unstructured":"Robel S.; Berninger B.; G\u00f6tz M.; The stem cell potential of glia: Lessons from reactive gliosis. Nat Rev Neurosci  2011,12(2),88-104","journal-title":"Nat Rev Neurosci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"AN20120010","DOI":"10.1042\/AN20120010","volume":"4","author":"Verkhratsky A.","year":"2012","unstructured":"Verkhratsky A.; Sofroniew M.V.; Messing A.; deLanerolle N.C.; Rempe D.; Rodr\u00edguez J.J.; Nedergaard M.; Neurological diseases as primary gliopathies: A reassessment of neurocentrism. ASN Neuro  2012,4(3),AN20120010","journal-title":"ASN Neuro"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4103\/1673-5374.290881","volume":"16","author":"Yang Z-Y.","year":"2021","unstructured":"Yang Z-Y.; Jin W.L.; Xu Y.; Jin M.Z.; Microglia in neurodegenerative diseases. Neural Regen Res  2021,16(2),270-280","journal-title":"Neural Regen Res"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1177\/1073858413510208","volume":"20","author":"Verkhratsky A.","year":"2014","unstructured":"Verkhratsky A.; Rodr\u00edguez J.J.; Steardo L.; Astrogliopathology. Neuroscientist  2014,20(6),576-588","journal-title":"Neuroscientist"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neulet.2014.01.014","volume":"565","author":"Colangelo A.M.","year":"2014","unstructured":"Colangelo A.M.; Alberghina L.; Papa M.; Astrogliosis as a therapeutic target for neurodegenerative diseases. Neurosci Lett  2014,565,59-64","journal-title":"Neurosci Lett"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.tins.2009.08.002","volume":"32","author":"Sofroniew M.V.","year":"2009","unstructured":"Sofroniew M.V.; Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci  2009,32(12),638-647","journal-title":"Trends Neurosci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"a020628","DOI":"10.1101\/cshperspect.a020628","volume":"7","author":"Phatnani H.","year":"2015","unstructured":"Phatnani H.; Maniatis T.; Astrocytes in neurodegenerative disease. Cold Spring Harb Perspect Biol  2015,7(6),a020628","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"8748253","DOI":"10.1155\/2019\/8748253","volume":"2019","author":"Forni C.","year":"2019","unstructured":"Forni C.; Facchiano F.; Bartoli M.; Pieretti S.; Facchiano A.; D\u2019Arcangelo D.; Norelli S.; Valle G.; Nisini R.; Beninati S.; Tabolacci C.; Jadeja R.N.; Beneficial role of phytochemicals on oxidative stress and age-related diseases. Biomed Res Int  2019,2019,8748253","journal-title":"Biomed Res Int"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1002\/1097-0010(20000915)80:12<1744::AID-JSFA725>3.0.CO;2-W","volume":"80","author":"Dillard C.J.","year":"2000","unstructured":"Dillard C.J.; German J.B.; Phytochemicals: Nutraceuticals and human health. J Sci Food Agric  2000,80(12),1744-1756","journal-title":"J Sci Food Agric"},{"key":"ref=20","author":"Fazeli E.","year":"2023","unstructured":"Fazeli E.; Ghalibaf M.H.E.; Forouzanfar F.; Neuroprotective potency of safranal against neurological disorders. Curr Mol Med  2023","journal-title":"Curr Mol Med"},{"key":"ref=21","first-page":"363","volume":"23","author":"Aggarwal B.B.","year":"2003","unstructured":"Aggarwal B.B.; Kumar A.; Bharti A.C.; Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res  2003,23(1A),363-398","journal-title":"Anticancer Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/biof.1522","volume":"45","author":"Forouzanfar F.","year":"2019","unstructured":"Forouzanfar F.; Barreto G.; Majeed M.; Sahebkar A.; Modulatory effects of curcumin on heat shock proteins in cancer: A promising therapeutic approach. Biofactors  2019,45(5),631-640","journal-title":"Biofactors"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/978-3-030-56153-6_21","volume":"1291","author":"Forouzanfar F","year":"2021","unstructured":"Forouzanfar F; Majeed M; Jamialahmadi T; Sahebkar A.; Curcumin: A review of its effects on epilepsy. Adv Exp Med Biol  2021,1291,363-373","journal-title":"Adv Exp Med Biol"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-3-030-55035-6_10","author":"Forouzanfar F.","year":"2021","unstructured":"Forouzanfar F.; Majeed M.; Jamialahmadi T.; Sahebkar A.; Telomerase: A target for therapeutic effects of curcumin in cancer. Adv Exp Med Biol  2021,135-143","journal-title":"Adv Exp Med Biol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/ptr.6037","volume":"32","author":"Mantzorou M.","year":"2018","unstructured":"Mantzorou M.; Pavlidou E.; Vasios G.; Tsagalioti E.; Giaginis C.; Effects of curcumin consumption on human chronic diseases: A narrative review of the most recent clinical data. Phytother Res  2018,32(6),957-975","journal-title":"Phytother Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2174\/092986732102131206115810","volume":"21","author":"Marchiani A.","year":"2013","unstructured":"Marchiani A.; Rozzo C.; Fadda A.; Delogu G.; Ruzza P.; Curcumin and curcumin-like molecules: From spice to drugs. Curr Med Chem  2013,21(2),204-222","journal-title":"Curr Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.3390\/ijms20102419","volume":"20","author":"Mhillaj E.","year":"2019","unstructured":"Mhillaj E.; Tarozzi A.; Pruccoli L.; Cuomo V.; Trabace L.; Mancuso C.; Curcumin and heme oxygenase: Neuroprotection and beyond. Int J Mol Sci  2019,20(10),2419","journal-title":"Int J Mol Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/nu11051004","volume":"11","author":"Yang M.","year":"2019","unstructured":"Yang M.; Akbar U.; Mohan C.; Curcumin in autoimmune and rheumatic diseases. Nutrients  2019,11(5),1004","journal-title":"Nutrients"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.phrs.2016.11.017","volume":"115","author":"Lelli D.","year":"2017","unstructured":"Lelli D.; Sahebkar A.; Johnston T.P.; Pedone C.; Curcumin use in pulmonary diseases: State of the art and future perspectives. Pharmacol Res  2017,115,133-148","journal-title":"Pharmacol Res"},{"key":"ref=30","doi-asserted-by":"publisher","unstructured":"Mokhtari-Zaer, A., Marefati, N., Atkin, S. L., Butler, A. E., and Sahebkar, A. (2018). The protective role of curcumin in myocardial ischemia-reperfusion injury. J. Cellular Physiol., 2018, 234(1), 214-222.","DOI":"10.1002\/jcp.268481"},{"key":"ref=31","doi-asserted-by":"publisher","unstructured":"Mohajeri, M., and Sahebkar, A. (2018). Protective effects of curcumin against doxorubicin-induced toxicity and resistance: A review. Crit. Rev. Oncol.,  2018, 122, 30-51.","DOI":"10.1016\/j.critrevonc.2017.12.005"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/ptr.7350","volume":"36","author":"Heidari Z.","year":"2022","unstructured":"Heidari Z.; Daei M.; Boozari M.; Jamialahmadi T.; Sahebkar A.; Curcumin supplementation in pediatric patients: A systematic review of current clinical evidence. Phytother Res  2022,36(4),1442-1458","journal-title":"Phytother Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"113621","DOI":"10.1016\/j.biopha.2022.113621","volume":"154","author":"Khayatan D.","year":"2022","unstructured":"Khayatan D.; Razavi S.M.; Arab Z.N.; Niknejad A.H.; Nouri K.; Momtaz S.; Gumpricht E.; Jamialahmadi T.; Abdolghaffari A.H.; Barreto G.E.; Sahebkar A.; Protective effects of curcumin against traumatic brain injury. Biomed Pharmacother  2022,154,113621","journal-title":"Biomed Pharmacother"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1002\/ptr.6991","volume":"35","author":"Soltani S.","year":"2021","unstructured":"Soltani S.; Boozari M.; Cicero A.F.G.; Jamialahmadi T.; Sahebkar A.; Effects of phytochemicals on macrophage cholesterol efflux capacity: Impact on atherosclerosis. Phytother Res  2021,35(6),2854-2878","journal-title":"Phytother Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.3390\/ijms20153757","volume":"20","author":"Bachmeier BA-O","year":"2019","unstructured":"Bachmeier BA-O; Melchart D; Therapeutic effects of curcumin\u2014from traditional past to present and future clinical applications. Int J Mol Sci  2019,20(15),3757","journal-title":"Int J Mol Sci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.3390\/ijms24043323","volume":"24","author":"Zeng Y.","year":"2023","unstructured":"Zeng Y.; Luo Y.; Wang L.; Zhang K.; Peng J.; Fan G.; Therapeutic effect of curcumin on metabolic diseases: Evidence from clinical studies. Int J Mol Sci  2023,24(4),3323","journal-title":"Int J Mol Sci"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-0-387-46401-5_3","volume":"595","author":"Menon V.P.","year":"2007","unstructured":"Menon V.P.; Sudheer A.R.; Antioxidant and anti-inflammatory properties of curcumin. The molecular targets and therapeutic uses of curcumin in health and disease. Adv Exp Med Biol  2007,595,105-25","journal-title":"Adv Exp Med Biol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.autrev.2017.11.016","volume":"17","author":"Momtazi-Borojeni A.A.","year":"2018","unstructured":"Momtazi-Borojeni A.A.; Haftcheshmeh S.M.; Esmaeili S.A.; Johnston T.P.; Abdollahi E.; Sahebkar A.; Curcumin: A natural modulator of immune cells in systemic lupus erythematosus. Autoimmun Rev  2018,17(2),125-135","journal-title":"Autoimmun Rev"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1089\/107555303321223035","volume":"9","author":"Chainani-Wu N.","year":"2003","unstructured":"Chainani-Wu N.; Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa). J Altern Complement Med  2003,9(1),161-168","journal-title":"J Altern Complement Med"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.phrs.2016.03.026","volume":"107","author":"Sahebkar A.","year":"2016","unstructured":"Sahebkar A.; Cicero A.F.G.; Simental-Mend\u00eda L.E.; Aggarwal B.B.; Gupta S.C.; Curcumin downregulates human tumor necrosis factor-\u03b1 levels: A systematic review and meta-analysis ofrandomized controlled trials. Pharmacol Res  2016,107,234-242","journal-title":"Pharmacol Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"104921","DOI":"10.1016\/j.phrs.2020.104921","volume":"159","author":"Hasanzadeh S.","year":"2020","unstructured":"Hasanzadeh S.; Read M.I.; Bland A.R.; Majeed M.; Jamialahmadi T.; Sahebkar A.; Curcumin: An inflammasome silencer. Pharmacol Res  2020,159,104921","journal-title":"Pharmacol Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/WNR.0b013e328314decb","volume":"20","author":"Matsushita Y.","year":"2009","unstructured":"Matsushita Y.; Ueda H.; Curcumin blocks chronic morphine analgesic tolerance and brain-derived neurotrophic factor upregulation. Neuroreport  2009,20(1),63-68","journal-title":"Neuroreport"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.phrs.2018.09.012","volume":"136","author":"Parsamanesh N.","year":"2018","unstructured":"Parsamanesh N.; Moossavi M.; Bahrami A.; Butler A.E.; Sahebkar A.; Therapeutic potential of curcumin in diabetic complications. Pharmacol Res  2018,136,181-193","journal-title":"Pharmacol Res"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1128\/AAC.01242-08","volume":"53","author":"De R.","year":"2009","unstructured":"De R.; Kundu P.; Swarnakar S.; Ramamurthy T.; Chowdhury A.; Nair G.B.; Mukhopadhyay A.K.; Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob Agents Chemother  2009,53(4),1592-1597","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4251\/wjgo.v2.i4.169","volume":"2","author":"Park J.","year":"2010","unstructured":"Park J.; Conteas C.N.; Anti-carcinogenic properties of curcumin on colorectal cancer. World J Gastrointest Oncol  2010,2(4),169-176","journal-title":"World J Gastrointest Oncol"},{"key":"ref=46","doi-asserted-by":"publisher","unstructured":"Momtazi, A A.; Sahebkar, A. Difluorinated curcumin: A promising curcumin analogue with improved anti-tumor activity and pharmacokinetic profile. Curr. Pharma. Desi., 2016, 22(28), 4386-4397.","DOI":"10.2174\/1381612822666160527113501"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10787-017-0402-8","volume":"26","author":"Sharma N.","year":"2018","unstructured":"Sharma N.; Nehru B.; Curcumin affords neuroprotection and inhibits \u03b1-synuclein aggregation in lipopolysaccharide-induced Parkinson\u2019s disease model. Inflammopharmacology  2018,26(2),349-360","journal-title":"Inflammopharmacology"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3109\/00207454.2011.648760","volume":"122","author":"Tripanichkul W.","year":"2012","unstructured":"Tripanichkul W.; Jaroensuppaperch E.; Curcumin protects nigrostriatal dopaminergic neurons and reduces glial activation in 6-hydroxydopamine hemiparkinsonian mice model. Int J Neurosci  2012,122(5),263-270","journal-title":"Int J Neurosci"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.npep.2009.05.002","volume":"43","author":"Sanchez A.","year":"2009","unstructured":"Sanchez A.; Tripathy D.; Grammas P.; RANTES release contributes to the protective action of PACAP38 against sodium nitroprusside in cortical neurons. Neuropeptides  2009,43(4),315-320","journal-title":"Neuropeptides"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.pnpbp.2010.12.022","volume":"35","author":"Lin M.S.","year":"2011","unstructured":"Lin M.S.; Hung K.S.; Chiu W.T.; Sun Y.Y.; Tsai S.H.; Lin J.W.; Lee Y.H.; Curcumin enhances neuronal survival in N-methyl-d-aspartic acid toxicity by inducing RANTES expression in astrocytes via PI-3K and MAPK signaling pathways. Prog Neuropsychopharmacol Biol Psychiatry  2011,35(4),931-938","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3233\/JAD-170093","volume":"60","author":"Sundaram J.R.","year":"2017","unstructured":"Sundaram J.R.; Poore C.P.; Sulaimee N.H.B.; Pareek T.; Cheong W.F.; Wenk M.R.; Pant H.C.; Frautschy S.A.; Low C.M.; Kesavapany S.; Curcumin ameliorates neuroinflammation, neurodegeneration, and memory deficits in p25 transgenic mouse model that bears hallmarks of Alzheimer\u2019s disease. J Alzheimers Dis  2017,60(4),1429-1442","journal-title":"J Alzheimers Dis"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s12192-016-0695-3","volume":"21","author":"Yu S.","year":"2016","unstructured":"Yu S.; Wang X.; He X.; Wang Y.; Gao S.; Ren L.; Shi Y.; Curcumin exerts anti-inflammatory and antioxidative properties in 1-methyl-4-phenylpyridinium ion (MPP+)-stimulated mesencephalic astrocytes by interference with TLR4 and downstream signaling pathway. Cell Stress Chaperones  2016,21(4),697-705","journal-title":"Cell Stress Chaperones"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"767","DOI":"10.2174\/1871527317666180720162029","volume":"17","author":"Chico L.","year":"2018","unstructured":"Chico L.; Ienco E.C.; Bisordi C.; Lo Gerfo A.; Petrozzi L.; Petrucci A.; Mancuso M.; Siciliano G.; Amyotrophic lateral sclerosis and oxidative stress: A double-blind therapeutic trial after curcumin supplementation. CNS Neurol Disord Drug Targets  2018,17(10),767-779","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s13311-018-0606-7","volume":"15","author":"Ahmadi M.","year":"2018","unstructured":"Ahmadi M.; Agah E.; Nafissi S.; Jaafari M.R.; Harirchian M.H.; Sarraf P.; Faghihi-Kashani S.; Hosseini S.J.; Ghoreishi A.; Aghamollaii V.; Hosseini M.; Tafakhori A.; Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: A pilot randomized clinical trial. Neurotherapeutics  2018,15(2),430-438","journal-title":"Neurotherapeutics"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/jcp.0b013e318160862c","volume":"28","author":"Baum L.","year":"2008","unstructured":"Baum L.; Lam C.W.K.; Cheung S.K.K.; Kwok T.; Lui V.; Tsoh J.; Lam L.; Leung V.; Hui E.; Ng C.; Woo J.; Chiu H.F.K.; Goggins W.B.; Zee B.C.Y.; Cheng K.F.; Fong C.Y.S.; Wong A.; Mok H.; Chow M.S.S.; Ho P.C.; Ip S.P.; Ho C.S.; Yu X.W.; Lai C.Y.L.; Chan M.H.; Szeto S.; Chan I.H.S.; Mok V.; Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol  2008,28(1),110-113","journal-title":"J Clin Psychopharmacol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/alzrt146","volume":"4","author":"Ringman J.M.","year":"2012","unstructured":"Ringman J.M.; Frautschy S.A.; Teng E.; Begum A.N.; Bardens J.; Beigi M.; Gylys K.H.; Badmaev V.; Heath D.D.; Apostolova L.G.; Porter V.; Vanek Z.; Marshall G.A.; Hellemann G.; Sugar C.; Masterman D.L.; Montine T.J.; Cummings J.L.; Cole G.M.; Oral curcumin for Alzheimer\u2019s disease: Tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res Ther  2012,4(5),43","journal-title":"Alzheimers Res Ther"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.4103\/1673-5374.235075","volume":"13","author":"Yuan C-X.","year":"2018","unstructured":"Yuan C-X.; Yang X-M.; Ye Q.; Yuan X-L.; Zhang H-Z.; Zishenpingchan granules for the treatment of Parkinson\u2019s disease: A randomized, double-blind, placebo-controlled clinical trial. Neural Regen Res  2018,13(7),1269-1275","journal-title":"Neural Regen Res"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"6862","DOI":"10.1002\/ptr.7273","volume":"35","author":"Mohseni M.","year":"2021","unstructured":"Mohseni M.; Sahebkar A.; Askari G.; Johnston T.P.; Alikiaii B.; Bagherniya M.; The clinical use of curcumin on neurological disorders: An updated systematic review of clinical trials. Phytother Res  2021,35(12),6862-6882","journal-title":"Phytother Res"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/B978-0-12-818553-7.00011-5","author":"Forouzanfar F.","year":"2020","unstructured":"Forouzanfar F.; Hosseinzadeh H.; Protective role of Nigella sativa and thymoquinone in oxidative stress: A review. Nuts and seeds in health and disease prevention. Academic Press  2020,127-146","journal-title":"Academic Press"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/15569543.2018.1514637","volume":"39","author":"Mashayekhi-Sardoo H.","year":"2020","unstructured":"Mashayekhi-Sardoo H.; Rezaee R.; Karimi G.; An overview of in vivo toxicological profile of thymoquinone. Toxin Rev  2020,39(2),115-122","journal-title":"Toxin Rev"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.molliq.2018.10.104","volume":"272","author":"Ahmad A.","year":"2018","unstructured":"Ahmad A.; Raish M.; Alkharfy K.M.; Alsarra I.A.; Khan A.; Ahad A.; Jan B.L.; Shakeel F.; Solubility, solubility parameters and solution thermodynamics of thymoquinone in different mono solvents. J Mol Liq  2018,272,912-918","journal-title":"J Mol Liq"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.biocel.2005.10.009","volume":"38","author":"Gali-Muhtasib H.","year":"2006","unstructured":"Gali-Muhtasib H.; Roessner A.; Schneider-Stock R.; Thymoquinone: A promising anti-cancer drug from natural sources. Int J Biochem Cell Biol  2006,38(8),1249-1253","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3390\/ijms18050919","volume":"18","author":"Atta M.","year":"2017","unstructured":"Atta M.; Almadaly E.; El-Far A.; Saleh R.; Assar D.; Al Jaouni S.; Mousa S.; Thymoquinone defeats diabetes-induced testicular damage in rats targeting antioxidant, inflammatory and aromatase expression. Int J Mol Sci  2017,18(5),919","journal-title":"Int J Mol Sci"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.intimp.2015.06.023","volume":"28","author":"Majdalawieh A.F.","year":"2015","unstructured":"Majdalawieh A.F.; Fayyad M.W.; Immunomodulatory and anti-inflammatory action of Nigella sativa and thymoquinone: A comprehensive review. Int Immunopharmacol  2015,28(1),295-304","journal-title":"Int Immunopharmacol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1007\/s00253-018-8736-8","volume":"102","author":"Goel S.","year":"2018","unstructured":"Goel S.; Mishra P.; Thymoquinone inhibits biofilm formation and has selective antibacterial activity due to ROS generation. Appl Microbiol Biotechnol  2018,102(4),1955-1967","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s12031-013-0043-3","volume":"51","author":"Dariani S.","year":"2013","unstructured":"Dariani S.; Baluchnejadmojarad T.; Roghani M.; Thymoquinone attenuates astrogliosis, neurodegeneration, mossy fiber sprouting, and oxidative stress in a model of temporal lobe epilepsy. J Mol Neurosci  2013,51(3),679-686","journal-title":"J Mol Neurosci"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1055\/s-0035-1568274","volume":"82","author":"Amoah S.","year":"2016","unstructured":"Amoah S.; Sandjo L.; Kratz J.; Biavatti M.; Rosmarinic acid-pharmaceutical and clinical aspects. Planta Med  2016,82(5),388-406","journal-title":"Planta Med"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.measurement.2016.04.033","volume":"89","author":"Nicolai M.","year":"2016","unstructured":"Nicolai M.; Pereira P.; Vitor R.F.; Reis C.P.; Roberto A.; Rijo P.; Antioxidant activity and rosmarinic acid content of ultrasound-assisted ethanolic extracts of medicinal plants. Measurement  2016,89,328-332","journal-title":"Measurement"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/bcpt.12335","volume":"116","author":"Rocha J.","year":"2015","unstructured":"Rocha J.; Eduardo-Figueira M.; Barateiro A.; Fernandes A.; Brites D.; Bronze R.; Duarte C.M.M.; Serra A.T.; Pinto R.; Freitas M.; Fernandes E.; Silva-Lima B.; Mota-Filipe H.; Sepodes B.; Anti-inflammatory effect of rosmarinic acid and an extract of Rosmarinus officinalis in rat models of local and systemic inflammation. Basic Clin Pharmacol Toxicol  2015,116(5),398-413","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"7775","DOI":"10.1007\/s00253-018-9223-y","volume":"102","author":"Swamy M.K.","year":"2018","unstructured":"Swamy M.K.; Sinniah U.R.; Ghasemzadeh A.; Anticancer potential of rosmarinic acid and its improved production through biotechnological interventions and functional genomics. Appl Microbiol Biotechnol  2018,102(18),7775-7793","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2018.04.008","volume":"118","author":"Kantar Gok D.","year":"2018","unstructured":"Kantar Gok D.; Hidisoglu E.; Ocak G.A.; Er H.; Acun A.D.; Yarg\u0131coglu P.; Protective role of rosmarinic acid on amyloid beta 42-induced echoic memory decline: Implication of oxidative stress and cholinergic impairment. Neurochem Int  2018,118,1-13","journal-title":"Neurochem Int"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"18627","DOI":"10.1038\/s41598-020-73729-2","volume":"10","author":"Noguchi-Shinohara M.","year":"2020","unstructured":"Noguchi-Shinohara M.; Ono K.; Hamaguchi T.; Nagai T.; Kobayashi S.; Komatsu J.; Samuraki-Yokohama M.; Iwasa K.; Yokoyama K.; Nakamura H.; Yamada M.; Safety and efficacy of Melissa officinalis extract containing rosmarinic acid in the prevention of Alzheimer\u2019s disease progression. Sci Rep  2020,10(1),18627","journal-title":"Sci Rep"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/2221-1691.250849","volume":"9","author":"Mahboubi M.","year":"2019","unstructured":"Mahboubi M.; Melissa officinalis and rosmarinic acid in management of memory functions and Alzheimer disease. Asian Pac J Trop Biomed  2019,9(2),47","journal-title":"Asian Pac J Trop Biomed"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neuro.2014.10.002","volume":"45","author":"Ahmad S.","year":"2014","unstructured":"Ahmad S.; Elsherbiny N.M.; Haque R.; Khan M.B.; Ishrat T.; Shah Z.A.; Khan M.M.; Ali M.; Jamal A.; Katare D.P.; Liou G.I.; Bhatia K.; Sesamin attenuates neurotoxicity in mouse model of ischemic brain stroke. Neurotoxicology  2014,45,100-110","journal-title":"Neurotoxicology"},{"key":"ref=75","first-page":"41","volume":"80","author":"Martinchik A.N.","year":"2011","unstructured":"Martinchik A.N.; Nutritional value of sesame seeds. Vopr Pitan  2011,80(3),41-43","journal-title":"Vopr Pitan"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.3390\/nu6051931","volume":"6","author":"Monteiro \u00c9.","year":"2014","unstructured":"Monteiro \u00c9.; Chibli L.; Yamamoto C.; Pereira M.; Vilela F.; Rodarte M.; de Oliveira Pinto M.; da Penha Henriques do Amaral M.; Silv\u00e9rio M.; de Matos Ara\u00fajo A.; da Luz Andr\u00e9 de Ara\u00fajo A.; Del-Vechio-Vieira G.; de Sousa O.; Antinociceptive and anti-inflammatory activities of the sesame oil and sesamin. Nutrients  2014,6(5),1931-1944","journal-title":"Nutrients"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/j.neuropharm.2012.01.012","volume":"62","author":"Zhang M.","year":"2012","unstructured":"Zhang M.; Lee H.J.; Park K.H.; Park H.J.; Choi H.S.; Lim S.C.; Lee M.K.; Modulatory effects of sesamin on dopamine biosynthesis and l-DOPA-induced cytotoxicity in PC12 cells. Neuropharmacology  2012,62(7),2219-2226","journal-title":"Neuropharmacology"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neulet.2004.05.073","volume":"367","author":"Hou R.C.W.","year":"2004","unstructured":"Hou R.C.W.; Wu C.C.; Yang C.H.; Jeng K.C.G.; Protective effects of sesamin and sesamolin on murine BV-2 microglia cell line under hypoxia. Neurosci Lett  2004,367(1),10-13","journal-title":"Neurosci Lett"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.biopha.2017.01.123","volume":"88","author":"Baluchnejadmojarad T.","year":"2017","unstructured":"Baluchnejadmojarad T.; Mansouri M.; Ghalami J.; Mokhtari Z.; Roghani M.; Sesamin imparts neuroprotection against intrastriatal 6-hydroxydopamine toxicity by inhibition of astroglial activation, apoptosis, and oxidative stress. Biomed Pharmacother  2017,88,754-761","journal-title":"Biomed Pharmacother"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"820969","DOI":"10.3389\/fphar.2022.820969","volume":"13","author":"Goh YX","year":"2022","unstructured":"Goh YX; Jalil J; Lam KW; Husain K; Premakumar CM; Genistein: A review on its anti-inflammatory properties. Front Pharmacol  2022,13,820969","journal-title":"Front Pharmacol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.intimp.2011.01.036","volume":"11","author":"Ji G.","year":"2011","unstructured":"Ji G.; Yang Q.; Hao J.; Guo L.; Chen X.; Hu J.; Leng L.; Jiang Z.; Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms. Int Immunopharmacol  2011,11(6),762-768","journal-title":"Int Immunopharmacol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.nlm.2010.12.001","volume":"95","author":"Bagheri M.","year":"2011","unstructured":"Bagheri M.; Joghataei M.T.; Mohseni S.; Roghani M.; Genistein ameliorates learning and memory deficits in amyloid \u03b2(1-40) rat model of Alzheimer\u2019s disease. Neurobiol Learn Mem  2011,95(3),270-276","journal-title":"Neurobiol Learn Mem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.brainres.2011.10.020","volume":"1429","author":"Bagheri M.","year":"2012","unstructured":"Bagheri M.; Roghani M.; Joghataei M.T.; Mohseni S.; Genistein inhibits aggregation of exogenous amyloid-beta1-40 and alleviates astrogliosis in the hippocampus of rats. Brain Res  2012,1429,145-154","journal-title":"Brain Res"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"e76526","DOI":"10.1371\/journal.pone.0076526","volume":"8","author":"Bagheri M.","year":"2013","unstructured":"Bagheri M.; Rezakhani A.; Nystr\u00f6m S.; Turkina M.V.; Roghani M.; Hammarstr\u00f6m P.; Mohseni S.; Amyloid beta(1-40)-induced astrogliosis and the effect of genistein treatment in rat: A three-dimensional confocal morphometric and proteomic study. PLoS One  2013,8(10),e76526","journal-title":"PLoS One"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.brainres.2009.11.044","volume":"1312","author":"Valles S.L.","year":"2010","unstructured":"Valles S.L.; Dolz-Gaiton P.; Gambini J.; Borras C.; LLoret A.; Pallardo F.V.; Vi\u00f1a J.; Estradiol or genistein prevent Alzheimer\u2019s disease-associated inflammation correlating with an increase PPAR\u03b3 expression in cultured astrocytes. Brain Res  2010,1312,138-144","journal-title":"Brain Res"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cyto.2017.10.008","volume":"104","author":"Mirahmadi S.M.S.","year":"2018","unstructured":"Mirahmadi S.M.S.; Shahmohammadi A.; Rousta A.M.; Azadi M.R.; Fahanik-Babaei J.; Baluchnejadmojarad T.; Roghani M.; Soy isoflavone genistein attenuates lipopolysaccharide-induced cognitive impairments in the rat via exerting anti-oxidative and anti-inflammatory effects. Cytokine  2018,104,151-159","journal-title":"Cytokine"},{"key":"ref=87","author":"Bagheri M.","year":"2012","unstructured":"Bagheri M.; Rezakhani A.; Nystr\u00f6m S.; Turkina M.V.; Roghani M.; Hammarstr\u00f6m P.; Mohseni S.; Genistein inhibits A\u03b21-40-induced astrogliosis: A three-dimensional confocal morphometric analysis.  2012"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s11481-019-09866-x","volume":"14","author":"Zhao Z.","year":"2019","unstructured":"Zhao Z.; Fu J.; Li S.; Li Z.; Neuroprotective effects of genistein in a sod1-g93a transgenic mouse model of amyotrophic lateral sclerosis. J Neuroimmune Pharmacol  2019,14(4),688-696","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13195-022-01097-2","volume":"14","author":"Vi\u00f1a J.","year":"2022","unstructured":"Vi\u00f1a J.; Escudero J.; Baquero M.; Cebri\u00e1n M.; Carbonell-As\u00edns J.A.; Mu\u00f1oz J.E.; Satorres E.; Mel\u00e9ndez J.C.; Ferrer-Rebolleda J.; C\u00f3zar-Santiago M.P.; Santab\u00e1rbara-G\u00f3mez J.M.; Jov\u00e9 M.; Pamplona R.; Tarazona-Santabalbina F.J.; Borr\u00e1s C.; Genistein effect on cognition in prodromal Alzheimer\u2019s disease patients. The GENIAL clinical trial. Alzheimers Res Ther  2022,14(1),164","journal-title":"Alzheimers Res Ther"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.intimp.2008.10.008","volume":"9","author":"Fan S.","year":"2009","unstructured":"Fan S.; Zhang Z.; Zheng Y.; Lu J.; Wu D.; Shan Q.; Hu B.; Wang Y.; Troxerutin protects the mouse kidney from d-galactose-caused injury through anti-inflammation and anti-oxidation. Int Immunopharmacol  2009,9(1),91-96","journal-title":"Int Immunopharmacol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.foodchem.2015.07.078","volume":"194","author":"Panat N.A.","year":"2016","unstructured":"Panat N.A.; Maurya D.K.; Ghaskadbi S.S.; Sandur S.K.; Troxerutin, a plant flavonoid, protects cells against oxidative stress-induced cell death through radical scavenging mechanism. Food Chem  2016,194,32-45","journal-title":"Food Chem"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jhazmat.2014.09.012","volume":"283","author":"Zhang Z.F.","year":"2015","unstructured":"Zhang Z.F.; Zhang Y.; Fan S.H.; Zhuang J.; Zheng Y.L.; Lu J.; Wu D.M.; Shan Q.; Hu B.; Troxerutin protects against 2,2\u2032,4,4\u2032-tetrabromodiphenyl ether (BDE-47)-induced liver inflammation by attenuating oxidative stress-mediated NAD+-depletion. J Hazard Mater  2015,283,98-109","journal-title":"J Hazard Mater"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejphar.2017.03.002","volume":"801","author":"Baluchnejadmojarad T.","year":"2017","unstructured":"Baluchnejadmojarad T.; Jamali-Raeufy N.; Zabihnejad S.; Rabiee N.; Roghani M.; Troxerutin exerts neuroprotection in 6-hydroxydopamine lesion rat model of Parkinson\u2019s disease: Possible involvement of PI3K\/ER\u03b2 signaling. Eur J Pharmacol  2017,801,72-78","journal-title":"Eur J Pharmacol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2174\/156800908786241050","volume":"8","author":"Lin Y.","year":"2008","unstructured":"Lin Y.; Shi R.; Wang X.; Shen H.M.; Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets  2008,8(7),634-646","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"108612","DOI":"10.1016\/j.biopha.2019.108612","volume":"112","author":"Imran M.","year":"2019","unstructured":"Imran M.; Rauf A.; Abu-Izneid T.; Nadeem M.; Shariati M.A.; Khan I.A.; Imran A.; Orhan I.E.; Rizwan M.; Atif M.; Gondal T.A.; Mubarak M.S.; Luteolin, a flavonoid, as an anticancer agent: A review. Biomed Pharmacother  2019,112,108612","journal-title":"Biomed Pharmacother"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/biof.1687","volume":"47","author":"Kempuraj D.","year":"2021","unstructured":"Kempuraj D.; Thangavel R.; Kempuraj D.D.; Ahmed M.E.; Selvakumar G.P.; Raikwar S.P.; Zaheer S.A.; Iyer S.S.; Govindarajan R.; Chandrasekaran P.N.; Zaheer A.; Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma. Biofactors  2021,47(2),190-197","journal-title":"Biofactors"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3389\/fphar.2017.00692","volume":"8","author":"Luo Y.","year":"2017","unstructured":"Luo Y.; Shang P.; Li D.; Luteolin: A flavonoid that has multiple cardio-protective effects and its molecular mechanisms. Front Pharmacol  2017,8,692","journal-title":"Front Pharmacol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.neuropharm.2014.07.012","volume":"86","author":"Patil S.P.","year":"2014","unstructured":"Patil S.P.; Jain P.D.; Sancheti J.S.; Ghumatkar P.J.; Tambe R.; Sathaye S.; RETRACTED: Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice. Neuropharmacology  2014,86,192-202","journal-title":"Neuropharmacology"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.2174\/1871527314666150821102823","volume":"14","author":"Siracusa R","year":"2015","unstructured":"Siracusa R; Paterniti I; Impellizzeri D; Cordaro M; Crupi R; Navarra M; The association of palmitoylethanolamide with luteolin decreases neuroinflammation and stimulates autophagy in Parkinson\u2019s disease model. CNS Neurol Disord Drug Targets  2015,14(10),1350-65","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.2174\/1871527313666140806124322","volume":"13","author":"Paterniti I","year":"2014","unstructured":"Paterniti I; Cordaro M; Campolo M; Siracusa R; Cornelius C; Navarra M; Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: The control of neuroinflammation. CNS Neurol Disord Drug Targets  2014,13(9),1530-41","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s11684-019-0724-6","volume":"14","author":"Song D.","year":"2020","unstructured":"Song D.; Hao J.; Fan D.; Biological properties and clinical applications of berberine. Front Med  2020,14(5),564-582","journal-title":"Front Med"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"345","DOI":"10.22270\/jddt.v10i5.4300","volume":"10","author":"Sondhi S.","year":"2020","unstructured":"Sondhi S.; Singh N.; Goyal K.; Jindal S.; A laconic review on extraction, biological activities of herbal formulations of berberine: A traditional drug. J Drug Deliv Ther  2020,10(5),345-357","journal-title":"J Drug Deliv Ther"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1211\/jpp.61.07.0001","volume":"61","author":"Ye M.","year":"2010","unstructured":"Ye M.; Fu S.; Pi R.; He F.; Neuropharmacological and pharmacokinetic properties of berberine: A review of recent research. J Pharm Pharmacol  2010,61(7),831-837","journal-title":"J Pharm Pharmacol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1471-2202-7-78","volume":"7","author":"Zhu F.","year":"2006","unstructured":"Zhu F.; Qian C.; Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer\u2019s disease. BMC Neurosci  2006,7(1),78","journal-title":"BMC Neurosci"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1016\/j.neurobiolaging.2012.02.016","volume":"33","author":"Durairajan S.S.K.","year":"2012","unstructured":"Durairajan S.S.K.; Liu L.F.; Lu J.H.; Chen L.L.; Yuan Q.; Chung S.K.; Huang L.; Li X.S.; Huang J.D.; Li M.; Berberine ameliorates \u03b2-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer\u2019s disease transgenic mouse model. Neurobiol Aging  2012,33(12),2903-2919","journal-title":"Neurobiol Aging"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11011-018-0349-5","volume":"34","author":"Sadraie S.","year":"2019","unstructured":"Sadraie S.; Kiasalari Z.; Razavian M.; Azimi S.; Sedighnejad L.; Afshin-Majd S.; Baluchnejadmojarad T.; Roghani M.; Berberine ameliorates lipopolysaccharide-induced learning and memory deficit in the rat: Insights into underlying molecular mechanisms. Metab Brain Dis  2019,34(1),245-255","journal-title":"Metab Brain Dis"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.biopha.2017.07.068","volume":"93","author":"Bie B.","year":"2017","unstructured":"Bie B.; Sun J.; Guo Y.; Li J.; Jiang W.; Yang J.; Huang C.; Li Z.; Baicalein: A review of its anti-cancer effects and mechanisms in Hepatocellular Carcinoma. Biomed Pharmacother  2017,93,1285-1291","journal-title":"Biomed Pharmacother"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2174\/1568006043586206","volume":"5","author":"Huang Y.","year":"2005","unstructured":"Huang Y.; Tsang S.Y.; Yao X.; Chen Z.Y.; Biological properties of baicalein in cardiovascular system. Curr Drug Targets Cardiovasc Haematol Disord  2005,5(2),177-184","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejmech.2017.03.004","volume":"131","author":"Dinda B.","year":"2017","unstructured":"Dinda B.; Dinda S.; DasSharma S.; Banik R.; Chakraborty A.; Dinda M.; Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders. Eur J Med Chem  2017,131,68-80","journal-title":"Eur J Med Chem"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1007\/s11064-016-2032-8","volume":"41","author":"Chen M.","year":"2016","unstructured":"Chen M.; Lai L.; Li X.; Zhang X.; He X.; Liu W.; Li R.; Ke X.; Fu C.; Huang Z.; Duan C.; Baicalein attenuates neurological deficits and preserves blood-brain barrier integrity in a rat model of intracerebral hemorrhage. Neurochem Res  2016,41(11),3095-3102","journal-title":"Neurochem Res"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/jnr.23307","volume":"92","author":"Lee E.","year":"2014","unstructured":"Lee E.; Park H.R.; Ji S.T.; Lee Y.; Lee J.; Baicalein attenuates astroglial activation in the 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine-induced Parkinson\u2019s disease model by downregulating the activations of nuclear factor-\u03baB, ERK, and JNK. J Neurosci Res  2014,92(1),130-139","journal-title":"J Neurosci Res"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.pbb.2009.03.008","volume":"92","author":"Mu X.","year":"2009","unstructured":"Mu X.; He G.; Cheng Y.; Li X.; Xu B.; Du G.; Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro. Pharmacol Biochem Behav  2009,92(4),642-648","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neulet.2008.05.116","volume":"441","author":"Cheng Y.","year":"2008","unstructured":"Cheng Y.; He G.; Mu X.; Zhang T.; Li X.; Hu J.; Xu B.; Du G.; Neuroprotective effect of baicalein against MPTP neurotoxicity: Behavioral, biochemical and immunohistochemical profile. Neurosci Lett  2008,441(1),16-20","journal-title":"Neurosci Lett"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"665031","DOI":"10.3389\/fphar.2021.665031","volume":"12","author":"Islam MS","year":"2021","unstructured":"Islam MS; Quispe C; Hossain R; Islam MT; Al-Harrasi A; Al-Rawahi A; Neuropharmacological effects of quercetin: A literature-based review. Front Pharmacol  2021,12,665031","journal-title":"Front Pharmacol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1249\/JSR.0b013e3181ae8959","volume":"8","author":"Davis J.M.","year":"2009","unstructured":"Davis J.M.; Murphy E.A.; Carmichael M.D.; Effects of the dietary flavonoid quercetin upon performance and health. Curr Sports Med Rep  2009,8(4),206-213","journal-title":"Curr Sports Med Rep"},{"key":"ref=116","volume":"4","author":"Aguirre L.","year":"2011","unstructured":"Aguirre L.; Arias N.; Teresa Macarulla M.; Gracia A.; Portillo M.P.; Beneficial effects of quercetin on obesity and diabetes. Open Nutraceuticals J  2011,4(1)","journal-title":"Open Nutraceuticals J"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neuropharm.2015.01.027","volume":"93","author":"Sabogal-Gu\u00e1queta A.M.","year":"2015","unstructured":"Sabogal-Gu\u00e1queta A.M.; Mu\u00f1oz-Manco J.I.; Ram\u00edrez-Pineda J.R.; Lamprea-Rodriguez M.; Osorio E.; Cardona-G\u00f3mez G.P.; The flavonoid quercetin ameliorates Alzheimer\u2019s disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer\u2019s disease model mice. Neuropharmacology  2015,93,134-145","journal-title":"Neuropharmacology"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ijpharm.2016.11.061","volume":"517","author":"Moreno L.C.G.I.","year":"2017","unstructured":"Moreno L.C.G.I.; Puerta E.; Su\u00e1rez-Santiago J.E.; Santos-Magalh\u00e3es N.S.; Ramirez M.J.; Irache J.M.; Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer\u2019s disease. Int J Pharm  2017,517(1-2),50-57","journal-title":"Int J Pharm"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.bbadis.2012.11.018","volume":"1832","author":"Sandhir R.","year":"2013","unstructured":"Sandhir R.; Mehrotra A.; Quercetin supplementation is effective in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: Implications in Huntington\u2019s disease. Biochim Biophys Acta Mol Basis Dis  2013,1832(3),421-430","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=120","first-page":"1237","volume":"10","author":"Lu Y.","year":"2018","unstructured":"Lu Y.; Liu Q.; Yu Q.; Quercetin enrich diet during the early-middle not middle-late stage of Alzheimer\u2019s disease ameliorates cognitive dysfunction. Am J Transl Res  2018,10(4),1237-1246","journal-title":"Am J Transl Res"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1021\/acs.jnatprod.5b00198","volume":"78","author":"Martinez R.M.","year":"2015","unstructured":"Martinez R.M.; Pinho-Ribeiro F.A.; Steffen V.S.; Caviglione C.V.; Vignoli J.A.; Barbosa D.S.; Baracat M.M.; Georgetti S.R.; Verri W.A.; Casagrande R.; Naringenin inhibits UVB irradiation-induced inflammation and oxidative stress in the skin of hairless mice. J Nat Prod  2015,78(7),1647-1655","journal-title":"J Nat Prod"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1179\/1743132815Y.0000000079","volume":"37","author":"Al-Rejaie S.S.","year":"2015","unstructured":"Al-Rejaie S.S.; Aleisa A.M.; Abuohashish H.M.; Parmar M.Y.; Ola M.S.; Al-Hosaini A.A.; Ahmed M.M.; Naringenin neutralises oxidative stress and nerve growth factor discrepancy in experimental diabetic neuropathy. Neurol Res  2015,37(10),924-933","journal-title":"Neurol Res"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bionut.2011.09.003","volume":"1","author":"Krishnakumar N.","year":"2011","unstructured":"Krishnakumar N.; Sulfikkarali N.; RajendraPrasad N.; Karthikeyan S.; Enhanced anticancer activity of naringenin-loaded nanoparticles in human cervical (HeLa) cancer cells. Biomedicine and Preventive Nutrition  2011,1(4),223-231","journal-title":"Biomedicine and Preventive Nutrition"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.phrs.2018.11.043","volume":"139","author":"Wang G.Q.","year":"2019","unstructured":"Wang G.Q.; Zhang B.; He X.M.; Li D.D.; Shi J.S.; Zhang F.; Naringenin targets on astroglial Nrf2 to support dopaminergic neurons. Pharmacol Res  2019,139,452-459","journal-title":"Pharmacol Res"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jsps.2016.04.025","volume":"25","author":"Ganeshpurkar A.","year":"2017","unstructured":"Ganeshpurkar A.; Saluja A.K.; The pharmacological potential of rutin. Saudi Pharm J  2017,25(2),149-164","journal-title":"Saudi Pharm J"},{"key":"ref=126","first-page":"59","volume":"14","author":"Al-Dhabi N.A.","year":"2015","unstructured":"Al-Dhabi N.A.; Arasu M.V.; Park C.H.; Park S.U.; An up-to-date review of rutin and its biological and pharmacological activities. EXCLI J  2015,14,59-63","journal-title":"EXCLI J"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0014-827X(01)01111-9","volume":"56","author":"Guardia T.","year":"2001","unstructured":"Guardia T.; Rotelli A.E.; Juarez A.O.; Pelzer L.E.; Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco  2001,56(9),683-687","journal-title":"Farmaco"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1640\/0002-8444(2008)98[98:AFRFPV]2.0.CO;2","volume":"98","author":"Singh M.","year":"2008","unstructured":"Singh M.; Govindarajan R.; Rawat A.K.S.; Khare P.B.; Antimicrobial flavonoid rutin from Pteris vittata L. against pathogenic gastrointestinal microflora. Am Fern J  2008,98(2),98-103","journal-title":"Am Fern J"},{"key":"ref=129","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12640-019-00086-y","volume":"37","author":"Abdelfattah M.S.","year":"2020","unstructured":"Abdelfattah M.S.; Badr S.E.A.; Lotfy S.A.; Attia G.H.; Aref A.M.; Abdel Moneim A.E.; Rutin and selenium Co-administration reverse 3-nitropropionic acid-induced neurochemical and molecular impairments in a mouse model of Huntington\u2019s disease. Neurotox Res  2020,37(1),77-92","journal-title":"Neurotox Res"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41698-017-0038-6","volume":"1","author":"Berman A.Y.","year":"2017","unstructured":"Berman A.Y.; Motechin R.A.; Wiesenfeld M.Y.; Holz M.K.; The therapeutic potential of resveratrol: A review of clinical trials. NPJ Precis Oncol  2017,1(1),35","journal-title":"NPJ Precis Oncol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.bbadis.2014.10.005","volume":"1852","author":"Kulkarni S.S.","year":"2015","unstructured":"Kulkarni S.S.; Cant\u00f3 C.; The molecular targets of resveratrol. Biochim Biophys Acta Mol Basis Dis  2015,1852(6),1114-1123","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"105188","DOI":"10.1016\/j.neuint.2021.105188","volume":"150","author":"Miguel C.A.","year":"2021","unstructured":"Miguel C.A.; Noya-Riob\u00f3 M.V.; Mazzone G.L.; Villar M.J.; Coronel M.F.; Antioxidant, anti-inflammatory and neuroprotective actions of resveratrol after experimental nervous system insults. Special focus on the molecular mechanisms involved. Neurochem Int  2021,150,105188","journal-title":"Neurochem Int"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10408398.2022.2101428","volume":"2022","author":"Wu S.X.","year":"2022","unstructured":"Wu S.X.; Xiong R.G.; Huang S.Y.; Zhou D.D.; Saimaiti A.; Zhao C.N.; Shang A.; Zhang Y.J.; Gan R.Y.; Li H.B.; Effects and mechanisms of resveratrol for prevention and management of cancers: An updated review. Crit Rev Food Sci Nutr  2022,2022,1-19","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/nure.12081","volume":"71","author":"Sahebkar A.","year":"2013","unstructured":"Sahebkar A.; Effects of resveratrol supplementation on plasma lipids: A systematic review and meta-analysis of randomized controlled trials. Nutr Rev  2013,71(12),822-835","journal-title":"Nutr Rev"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijcard.2015.04.008","volume":"189","author":"Sahebkar A.","year":"2015","unstructured":"Sahebkar A.; Serban C.; Ursoniu S.; Wong N.D.; Muntner P.; Graham I.M.; Mikhailidis D.P.; Rizzo M.; Rysz J.; Sperling L.S.; Lip G.Y.H.; Banach M.; Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors \u2014 Results from a systematic review and meta-analysis of randomized controlled trials. Int J Cardiol  2015,189(1),47-55","journal-title":"Int J Cardiol"},{"key":"ref=136","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.phrs.2014.08.001","volume":"90","author":"Tang PC","year":"2014","unstructured":"Tang PC; Ng YF; Ho S; Gyda M; Chan SW; Resveratrol and cardiovascular health - Promising therapeutic or hopeless illusion? Pharmacol Res  2014,90,88-115","journal-title":"Pharmacol Res"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"710","DOI":"10.2174\/1567205016666190801153751","volume":"16","author":"Sun X.Y.","year":"2019","unstructured":"Sun X.Y.; Dong Q.X.; Zhu J.; Sun X.; Zhang L.F.; Qiu M.; Yu X.L.; Liu R.T.; Resveratrol rescues tau-induced cognitive deficits and neuropathology in a mouse model of tauopathy. Curr Alzheimer Res  2019,16(8),710-722","journal-title":"Curr Alzheimer Res"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"937605","DOI":"10.1155\/2012\/937605","volume":"2012","author":"Zhang F","year":"2012","unstructured":"Zhang F; Wang Y-Y; Liu H; Lu Y-F; Wu Q; Liu J; Resveratrol produces neurotrophic effects on cultured dopaminergic neurons through prompting astroglial BDNF and GDNF release. Evid Based Complement Alternat Med  2012,2012,937605","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11010-016-2917-5","volume":"428","author":"Ar\u00fas B.A.","year":"2017","unstructured":"Ar\u00fas B.A.; Souza D.G.; Bellaver B.; Souza D.O.; Gon\u00e7alves C.A.; Quincozes-Santos A.; Bobermin L.D.; Resveratrol modulates GSH system in C6 astroglial cells through heme oxygenase 1 pathway. Mol Cell Biochem  2017,428(1-2),67-77","journal-title":"Mol Cell Biochem"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1007\/s11064-015-1636-8","volume":"40","author":"Bellaver B.","year":"2015","unstructured":"Bellaver B.; Souza D.G.; Bobermin L.D.; Souza D.O.; Gon\u00e7alves C.A.; Quincozes-Santos A.; Resveratrol protects hippocampal astrocytes against LPS-induced neurotoxicity through HO-1, p38 and ERK pathways. Neurochem Res  2015,40(8),1600-1608","journal-title":"Neurochem Res"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1007\/s12035-013-8401-2","volume":"47","author":"Frozza R.L.","year":"2013","unstructured":"Frozza R.L.; Bernardi A.; Hoppe J.B.; Meneghetti A.B.; Matt\u00e9 A.; Battastini A.M.O.; Pohlmann A.R.; Guterres S.S.; Salbego C.; Neuroprotective effects of resveratrol against A\u03b2 administration in rats are improved by lipid-core nanocapsules. Mol Neurobiol  2013,47(3),1066-1080","journal-title":"Mol Neurobiol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-016-0779-0","volume":"14","author":"Moussa C.","year":"2017","unstructured":"Moussa C.; Hebron M.; Huang X.; Ahn J.; Rissman R.A.; Aisen P.S.; Turner R.S.; Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer\u2019s disease. J Neuroinflammation  2017,14(1),1","journal-title":"J Neuroinflammation"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1212\/WNL.0000000000002035","volume":"85","author":"Turner R.S.","year":"2015","unstructured":"Turner R.S.; Thomas R.G.; Craft S.; van Dyck C.H.; Mintzer J.; Reynolds B.A.; Brewer J.B.; Rissman R.A.; Raman R.; Aisen P.S.; A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology  2015,85(16),1383-1391","journal-title":"Neurology"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0304-3959(89)90079-1","volume":"38","author":"Simone D.A.","year":"1989","unstructured":"Simone D.A.; Baumann T.K.; LaMotte R.H.; Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin. Pain  1989,38(1),99-107","journal-title":"Pain"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0898-6568(02)00086-4","volume":"15","author":"Kim C.S.","year":"2003","unstructured":"Kim C.S.; Kawada T.; Kim B.S.; Han I.S.; Choe S.Y.; Kurata T.; Yu R.; Capsaicin exhibits anti-inflammatory property by inhibiting IkB-a degradation in LPS-stimulated peritoneal macrophages. Cell Signal  2003,15(3),299-306","journal-title":"Cell Signal"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1021\/jp211172f","volume":"116","author":"Galano A.","year":"2012","unstructured":"Galano A.; Mart\u00ednez A.; Capsaicin, a tasty free radical scavenger: Mechanism of action and kinetics. J Phys Chem B  2012,116(3),1200-1208","journal-title":"J Phys Chem B"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1016\/j.febslet.2007.07.082","volume":"581","author":"Kang J.H.","year":"2007","unstructured":"Kang J.H.; Kim C.S.; Han I.S.; Kawada T.; Yu R.; Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages. FEBS Lett  2007,581(23),4389-4396","journal-title":"FEBS Lett"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"e298","DOI":"10.1038\/emm.2016.159","volume":"49","author":"Chung Y.C.","year":"2017","unstructured":"Chung Y.C.; Baek J.Y.; Kim S.R.; Ko H.W.; Bok E.; Shin W.H.; Won S.Y.; Jin B.K.; Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson\u2019s disease. Exp Mol Med  2017,49(3),e298","journal-title":"Exp Mol Med"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ijpharm.2005.03.031","volume":"298","author":"Garcia-Garcia E.","year":"2005","unstructured":"Garcia-Garcia E.; Andrieux K.; Gil S.; Couvreur P.; Colloidal carriers and blood-brain barrier (BBB) translocation: A way to deliver drugs to the brain? Int J Pharm  2005,298(2),274-292","journal-title":"Int J Pharm"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"4690","DOI":"10.1039\/C6CS00076B","volume":"45","author":"Oller-Salvia B.","year":"2016","unstructured":"Oller-Salvia B.; S\u00e1nchez-Navarro M.; Giralt E.; Teixid\u00f3 M.; Blood-brain barrier shuttle peptides: An emerging paradigm for brain delivery. Chem Soc Rev  2016,45(17),4690-4707","journal-title":"Chem Soc Rev"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.2174\/1381612822666151221150733","volume":"22","author":"Hersh D.S.","year":"2016","unstructured":"Hersh D.S.; Wadajkar A.S.; Roberts N.; Perez J.G.; Connolly N.P.; Frenkel V.; Winkles J.A.; Woodworth G.F.; Kim A.J.; Evolving drug delivery strategies to overcome the blood brain barrier. Curr Pharm Des  2016,22(9),1177-1193","journal-title":"Curr Pharm Des"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/pharmaceutics10040269","volume":"10","author":"Teleanu D.","year":"2018","unstructured":"Teleanu D.; Chircov C.; Grumezescu A.; Volceanov A.; Teleanu R.; Blood-brain delivery methods using nanotechnology. Pharmaceutics  2018,10(4),269","journal-title":"Pharmaceutics"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/cns.12189","volume":"20","author":"Chakraborty J.","year":"2014","unstructured":"Chakraborty J.; Singh R.; Dutta D.; Naskar A.; Rajamma U.; Mohanakumar K.P.; Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington\u2019s Disease. CNS Neurosci Ther  2014,20(1),10-19","journal-title":"CNS Neurosci Ther"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666230504121523","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/216530\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666230504121523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T13:35:39Z","timestamp":1727962539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/216530\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":153,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867330666230504121523","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-12-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}